Patents by Inventor Craig Steven Harris
Craig Steven Harris has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11939433Abstract: A method of preparing a hydrogel product including crosslinked glycosaminoglycan molecules, said method including: i) providing a glycosaminoglycan crosslinked by amide bonds, wherein the crosslinked glycosaminoglycans include residual amine groups; and ii) acylating residual amine groups of the crosslinked glycosaminoglycans provided in i) to form acylated crosslinked glycosaminoglycans.Type: GrantFiled: June 12, 2023Date of Patent: March 26, 2024Assignee: GALDERMA HOLDING S.A.Inventors: Johan Olsson, Craig Steven Harris
-
Patent number: 11888702Abstract: A services platform acts as an intermediary between an existing enterprise analytic environment, and one or more underlying cloud service providers. The platform provides enterprise “big data-as-a-service,” by which an enterprise can seamlessly and easily provision new capacity for processing its analytic workload, and migrate data sources (e.g., data warehouse marts, enterprise data warehouses, analytic sandboxes, and the like) to the cloud for processing. The platform provides end-to-end enterprise class manageability of enterprise data assets, from data collection, aggregation, movement, staging and processing, all while providing service levels, security, access and governance. The platform integrates directly but seamlessly into the enterprise analytic stack, and existing analytics applications work as normal. The platform provides a way for the enterprise to translate its workloads into clusters of compute resources that meet its service level requirements.Type: GrantFiled: February 1, 2022Date of Patent: January 30, 2024Assignee: Cazena, Inc.Inventors: Pratyush Moghe, Peter Thomas Smith, Craig Steven Harris, Mineharu Takahara, Lovantheran Chetty, Daniel Dietterich
-
Publication number: 20230416469Abstract: The invention relates to a hydrogel product comprising glycosaminoglycan molecules as the swellable polymer, wherein the glycosaminoglycan molecules are covalently crosslinked via crosslinks comprising a spacer group selected from the group consisting of di-, tri-, tetra-, and oligosaccharides.Type: ApplicationFiled: September 5, 2023Publication date: December 28, 2023Applicant: Galderma Holding SAInventors: Hotan MOJARRADI, Johan OLSSON, Craig Steven HARRIS, Jean-Guy BOITEAU, Thibaut GERFAUD, Loïc TOMAS
-
Patent number: 11807726Abstract: A new hydrogel made of crosslinked glycosaminoglycans, particularly crosslinked hyaluronic acid, chondroitin or chondroitin sulfate, having reversible linkages using boronic acid or boroxole derivatives leading to new benefits. Glycosaminoglycans that are crosslinked via an alkoxyboronate ester anion formed between a diol portion of a diol-functional moiety grafted to a first glycosaminoglycan and a boronate hemiester grafted to a second glycosaminoglycan.Type: GrantFiled: November 24, 2021Date of Patent: November 7, 2023Assignee: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUEInventors: Rachel Auzely-Velty, Tamiris Figueiredo, Laura Jing Jing, Craig Steven Harris, Jean-Guy Boiteau, Thibaut Gerfaud, Loic Tomas
-
Publication number: 20230323041Abstract: A method of preparing a hydrogel product including crosslinked glycosaminoglycan molecules, said method including: i) providing a glycosaminoglycan crosslinked by amide bonds, wherein the crosslinked glycosaminoglycans include residual amine groups; and ii) acylating residual amine groups of the crosslinked glycosaminoglycans provided in i) to form acylated crosslinked glycosaminoglycans.Type: ApplicationFiled: June 12, 2023Publication date: October 12, 2023Applicant: Galderma Holding SAInventors: Johan OLSSON, Craig Steven HARRIS
-
Patent number: 11708461Abstract: A method of preparing a hydrogel product including crosslinked glycosaminoglycan molecules, said method including: i) providing a glycosaminoglycan crosslinked by amide bonds, wherein the crosslinked glycosaminoglycans include residual amine groups; and ii) acylating residual amine groups of the crosslinked glycosaminoglycans provided in i) to form acylated crosslinked glycosaminoglycans.Type: GrantFiled: December 21, 2020Date of Patent: July 25, 2023Assignee: Galderma Holding SAInventors: Johan Olsson, Craig Steven Harris
-
Patent number: 11643509Abstract: The invention relates to a hydrogel product comprising glycosaminoglycan molecules as the swellable polymer, wherein the glycosaminoglycan molecules are covalently crosslinked via crosslinks comprising a spacer group selected from the group consisting of di-, tri-, tetra-, and oligosaccharides.Type: GrantFiled: November 29, 2022Date of Patent: May 9, 2023Assignee: Galderma Holding SAInventors: Hotan Mojarradi, Johan Olsson, Craig Steven Harris, Jean-Guy Boiteau, Thibaut Gerfaud, Loïc Tomas
-
Publication number: 20230102832Abstract: The invention relates to a hydrogel product comprising glycosaminoglycan molecules as the swellable polymer, wherein the glycosaminoglycan molecules are covalently crosslinked via crosslinks comprising a spacer group selected from the group consisting of di-, tri-, tetra-, and oligosaccharides.Type: ApplicationFiled: November 29, 2022Publication date: March 30, 2023Applicant: Galderma Holding SAInventors: Hotan MOJARRADI, Johan OLSSON, Craig Steven HARRIS, Jean-Guy BOITEAU, Thibaut GERFAUD, Loïc TOMAS
-
Publication number: 20220407781Abstract: A services platform acts as an intermediary between an existing enterprise analytic environment, and one or more underlying cloud service providers. The platform provides enterprise “big data-as-a-service,” by which an enterprise can seamlessly and easily provision new capacity for processing its analytic workload, and migrate data sources (e.g., data warehouse marts, enterprise data warehouses, analytic sandboxes, and the like) to the cloud for processing. The platform provides end-to-end enterprise class manageability of enterprise data assets, from data collection, aggregation, movement, staging and processing, all while providing service levels, security, access and governance. The platform integrates directly but seamlessly into the enterprise analytic stack, and existing analytics applications work as normal. The platform provides a way for the enterprise to translate its workloads into clusters of compute resources that meet its service level requirements.Type: ApplicationFiled: February 1, 2022Publication date: December 22, 2022Inventors: Pratyush Moghe, Peter Thomas Smith, Craig Steven Harris, Mineharu Takahara, Lovantheran Chetty, Daniel Dietterich
-
Patent number: 11530301Abstract: The invention relates to a hydrogel product comprising glycosaminoglycan molecules as the swellable polymer, wherein the glycosaminoglycan molecules are covalently crosslinked via crosslinks comprising a spacer group selected from the group consisting of di-, tri-, tetra-, and oligosaccharides.Type: GrantFiled: December 28, 2016Date of Patent: December 20, 2022Assignee: Galderma Holding SAInventors: Hotan Mojarradi, Johan Olsson, Craig Steven Harris, Jean-Guy Boiteau, Thibaut Gerfaud, Loïc Tomas
-
Publication number: 20220177655Abstract: A method for at least partial deacetylation of a biopolymer comprising acetyl groups, including: a1) providing a biopolymer including acetyl groups; a2) reacting the biopolymer including acetyl groups with hydroxylamine (NH2OH) or a salt thereof at a temperature of 100° C. or less for 2-200 hours to form an at least partially deacetylated biopolymer; and a3) recovering the at least partially deacetylated biopolymer.Type: ApplicationFiled: February 21, 2022Publication date: June 9, 2022Applicant: Galderma Holding SAInventors: Johan Olsson, Craig Steven Harris
-
Publication number: 20220081519Abstract: A new hydrogel made of crosslinked glycosaminoglycans, particularly crosslinked hyaluronic acid, chondroitin or chondroitin sulfate, having reversible linkages using boronic acid or boroxole derivatives leading to new benefits. Glycosaminoglycans that are crosslinked via an alkoxyboronate ester anion formed between a diol portion of a diol-functional moiety grafted to a first glycosaminoglycan and a boronate hemiester grafted to a second glycosaminoglycan.Type: ApplicationFiled: November 24, 2021Publication date: March 17, 2022Applicants: Galderma Research & Development, Centre National de la Recherche ScientifiqueInventors: Rachel AUZELY-VELTY, Tamiris FIGUEIREDO, Laura JING JING, Craig Steven HARRIS, Jean-Guy BOITEAU, Thibaut GERFAUD, Loic TOMAS
-
Patent number: 11254792Abstract: A method for at least partial deacetylation of a biopolymer comprising acetyl groups, including: a1) providing a biopolymer including acetyl groups; a2) reacting the biopolymer including acetyl groups with hydroxylamine (NH2OH) or a salt thereof at a temperature of 100° C. or less for 2-200 hours to form an at least partially deacetylated biopolymer; and a3) recovering the at least partially deacetylated biopolymer.Type: GrantFiled: December 28, 2016Date of Patent: February 22, 2022Assignee: GALDERMA HOLDING SAInventors: Johan Olsson, Craig Steven Harris
-
Patent number: 11240117Abstract: A services platform acts as an intermediary between an existing enterprise analytic environment, and one or more underlying cloud service providers. The platform provides enterprise “big data-as-a-service,” by which an enterprise can seamlessly and easily provision new capacity for processing its analytic workload, and migrate data sources (e.g., data warehouse marts, enterprise data warehouses, analytic sandboxes, and the like) to the cloud for processing. The platform provides end-to-end enterprise class manageability of enterprise data assets, from data collection, aggregation, movement, staging and processing, all while providing service levels, security, access and governance. The platform integrates directly but seamlessly into the enterprise analytic stack, and existing analytics applications work as normal. The platform provides a way for the enterprise to translate its workloads into clusters of compute resources that meet its service level requirements.Type: GrantFiled: April 1, 2019Date of Patent: February 1, 2022Assignee: Cazena, Inc.Inventors: Pratyush Moghe, Peter Thomas Smith, Craig Steven Harris, Mineharu Takahara, Lovantheran Chetty, Daniel Dietterich
-
Patent number: 11214655Abstract: A new hydrogel made of crosslinked glycosaminoglycans, particularly crosslinked hyaluronic acid, chondroitin or chondroitin sulfate, having reversible linkages using boronic acid or boroxole derivatives leading to new benefits. Glycosaminoglycans that are crosslinked via an alkoxyboronate ester anion formed between a diol portion of a diol-functional moiety grafted to a first glycosaminoglycan and a boronate hemiester grafted to a second glycosaminoglycan.Type: GrantFiled: August 2, 2017Date of Patent: January 4, 2022Assignees: GALDERMA RESEARCH & DEVELOPMENT, CENTRE NATIONAL DE LA RECHERCHE SCIENTFIQUEInventors: Rachel Auzely-Velty, Tamiris Figueiredo, Laura Jing Jing, Craig Steven Harris, Jean-Guy Boiteau, Thibaut Gerfaud, Loic Tomas
-
Patent number: 11066526Abstract: A method for cleaving amide bonds, comprising: a) providing a molecule comprising an amide group; b) reacting the molecule comprising an amide group with hydroxylamine (NH2OH) or a salt thereof to cleave the amide bond of the amide group.Type: GrantFiled: December 28, 2016Date of Patent: July 20, 2021Assignee: Galderma Holding SAInventors: Laura Jing Jing, Craig Steven Harris
-
Publication number: 20210108036Abstract: A method of preparing a hydrogel product including crosslinked glycosaminoglycan molecules, said method including: i) providing a glycosaminoglycan crosslinked by amide bonds, wherein the crosslinked glycosaminoglycans include residual amine groups; and ii) acylating residual amine groups of the crosslinked glycosaminoglycans provided in i) to form acylated crosslinked glycosaminoglycans.Type: ApplicationFiled: December 21, 2020Publication date: April 15, 2021Applicant: Galderma S.A.Inventors: Johan OLSSON, Craig Steven HARRIS
-
Patent number: 10954316Abstract: A method for cleaving amide bonds, including: a) providing a molecule including an amide group; b) reacting the molecule including the amide group with a hydroxylamine salt to cleave the amide bond of the amide group. The method may further include c) recovering a product formed by the reaction of step b).Type: GrantFiled: May 30, 2017Date of Patent: March 23, 2021Assignee: Galderma Holding SAInventors: Craig Steven Harris, Laura Jing Jing
-
Patent number: 10898613Abstract: A method of preparing a sterilized injectable hydrogel composition, including the steps: a) covalently crosslinking a glycosaminoglycan using a bi- or polyfunctional crosslinking agent to form a covalently crosslinked glycosaminoglycan, b) swelling the covalently crosslinked glycosaminoglycan in a solution including a divalent cation to form a hydrogel composition, and c) sterilizing the hydrogel composition by autoclaving to form a sterilized injectable hydrogel composition, and to sterilized injectable hydrogel compositions obtainable by such method.Type: GrantFiled: September 20, 2017Date of Patent: January 26, 2021Assignee: NESTLÉ SKIN HEALTH SAInventors: Laura Jing Jing, Craig Steven Harris, Anders Karlsson, Elin Säwén
-
Patent number: 10899894Abstract: A method of preparing a hydrogel product including crosslinked glycosaminoglycan molecules, said method including: i) providing a glycosaminoglycan crosslinked by amide bonds, wherein the crosslinked glycosaminoglycans include residual amine groups; and ii) acylating residual amine groups of the crosslinked glycosaminoglycans provided in i) to form acylated crosslinked glycosaminoglycans.Type: GrantFiled: December 28, 2016Date of Patent: January 26, 2021Assignee: GALDERMA S.AInventors: Johan Olsson, Craig Steven Harris